BioSante Pharmaceuticals, Inc.

Sector: Biological Products Except Diagnostic Substances Region: IL, United States

Exchange/Ticker: Nasdaq: BPAX

Company Description

BioSante Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on developing products for female sexual health, oncology, menopause, contraception and male hypogonadism. Its products either approved or in human clinical development, include LibiGel, a transdermal testosterone gel, which is used for the treatment of female sexual dysfunction; Elestrin, a transdermal estradiol gel, which is used for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; The Pill-Plus once daily use of various combinations of estrogens, progestogens and androgens that is used for the treatment of FSD in women using oral or transdermal contraceptives; Bio-T-Gel, a transdermal testosterone gel, which is used for the treatment of hypogonadism or testosterone deficiency in men; and cancer vaccines for the treatment of various cancers. The company is also developing its calcium phosphate technology for aesthetic medicine. BioSante Pharmaceuticals was founded in August 1996 and is headquartered in Lincolnshire, IL.

Similar to: Retrophin Inc, ALLENEX AB, BioTime, Inc.

Featured Company

Fidelity Asian Values Plc

Tadworth, SU, GB

Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →